Search results
Pfizer's drug for advanced lung cancer shows promising long-term trial results
CNBC· 14 hours agoPfizer on Friday said its drug for an advanced form of lung cancer showed promising long-term...
Novartis reports Phase III data for trials of remibrutinib to treat CSU
Clinical Trials Arena via Yahoo Finance· 17 hours agoNovartis has released new data from two Phase III clinical trials confirming the sustained efficacy...
Promising melanoma treatment advances to Phase 3 trial By Investing.com
Investing.com· 6 hours agoThe data presented at the American Society of Oncology (ASCO) 2024 Annual Meeting revealed that...
Lexicon selects Medidata to advance Phase IIb non-opioid pain drug trial
Clinical Trials Arena via Yahoo Finance· 2 days agoThis collaboration is aimed at accelerating clinical trials and improving the patient experience....
Gilead’s Phase III urothelial cancer trial fails to meet primary endpoint
Clinical Trials Arena via Yahoo Finance· 19 hours agoGilead plans to assess the trial data further and will consult with the Food and Drug Administration...
Ivonescimab shows promise in NSCLC Phase III trial By Investing.com
Investing.com· 1 day agoSummit Therapeutics Inc. (NASDAQ: NASDAQ:SMMT) announced that its Phase III clinical trial,...
Duchenne muscular dystrophy drug flunks Phase 3 confirmatory trial
Endpoints News· 4 days agoNS Pharma’s Duchenne muscular dystrophy drug Viltepso failed its confirmatory study. Despite the...
Pharma Billionaire's Fortune More Than Doubles In A Day On Cancer Drug Trial News
Forbes· 1 day agoShares of biotech firm Summit Therapeutics more than tripled on Thursday following good news about a...
Pfizer sees lung cancer drug topping $1 billion in sales following impressive 5-year data
FOX Business· 5 hours agoPfizer said it expects its cancer drug Lorbrena to top $1 billion in annual sales by 2030 on the...
Moderna's RSV vaccine for older adults approved
Axios· 7 hours agoModerna's RSV shot for adults 60 and older was approved by the Food and Drug Administration on Friday, joining a growing group of vaccines protecting...